G Ceccarini1, M Maffei2,3, P Vitti2, F Santini4. 1. Obesity Center at the Endocrine Unit, University Hospital of Pisa, Pisa, Italy. ceccarg@gmail.com. 2. Obesity Center at the Endocrine Unit, University Hospital of Pisa, Pisa, Italy. 3. National Research Council, Institute of Clinical Physiology, Pisa, Italy. 4. Obesity Center at the Endocrine Unit, University Hospital of Pisa, Pisa, Italy. ferruccio.santini@med.unipi.it.
Abstract
BACKGROUND: While it is now accepted that genes and their products affect food intake, the concept that locomotor behavior or the propensity for physical activity is controlled by neuro hum oral regulators is frequently underappreciated. In mammals, complex interactions have developed to allow the cross-talk between fuel homeostasis and physical activity. AIM: The aim of this review is to provide a synopsis of the influence of the leptin-melanocortin pathway, a well-studied pivotal player in body weight regulation, on locomotor behaviors. CONCLUSIONS: In rodents, reductions in leptin levels that physiologically occur following acute food deprivation or a reduction of the fat mass consequent to prolonged caloric restrictions are associated with a decrease in total locomotor activity and simultaneous increase in food-anticipatory activity, a locomotor behavior which reflects a foraging attitude. These actions can be prevented by leptin administration and are at least partially mediated by the neurons of the melanocortin pathway. In humans, twin studies have attributed to genetic factors approximately 50% of the variance of physical activity. An elevated number of the genes or loci which may affect physical activity are involved in body weight homeostasis. Polymorphisms of the melanocortin-4 and leptin receptors have repeatedly been associated with the level of physical activity. Unraveling the complexity of the regulation of locomotor behavior and the interconnections with the pathways involved in energy homeostasis may help explain the substantial individual variability in physical activities in humans and disentangle the harmful effects of sedentary lifestyle, which may be distinct from the detrimental effects of obesity.
BACKGROUND: While it is now accepted that genes and their products affect food intake, the concept that locomotor behavior or the propensity for physical activity is controlled by neuro hum oral regulators is frequently underappreciated. In mammals, complex interactions have developed to allow the cross-talk between fuel homeostasis and physical activity. AIM: The aim of this review is to provide a synopsis of the influence of the leptin-melanocortin pathway, a well-studied pivotal player in body weight regulation, on locomotor behaviors. CONCLUSIONS: In rodents, reductions in leptin levels that physiologically occur following acute food deprivation or a reduction of the fat mass consequent to prolonged caloric restrictions are associated with a decrease in total locomotor activity and simultaneous increase in food-anticipatory activity, a locomotor behavior which reflects a foraging attitude. These actions can be prevented by leptin administration and are at least partially mediated by the neurons of the melanocortin pathway. In humans, twin studies have attributed to genetic factors approximately 50% of the variance of physical activity. An elevated number of the genes or loci which may affect physical activity are involved in body weight homeostasis. Polymorphisms of the melanocortin-4 and leptin receptors have repeatedly been associated with the level of physical activity. Unraveling the complexity of the regulation of locomotor behavior and the interconnections with the pathways involved in energy homeostasis may help explain the substantial individual variability in physical activities in humans and disentangle the harmful effects of sedentary lifestyle, which may be distinct from the detrimental effects of obesity.
Authors: Roberto Coppari; Masumi Ichinose; Charlotte E Lee; Abigail E Pullen; Christopher D Kenny; Robert A McGovern; Vinsee Tang; Shun M Liu; Thomas Ludwig; Streamson C Chua; Bradford B Lowell; Joel K Elmquist Journal: Cell Metab Date: 2005-01 Impact factor: 27.287
Authors: Theodore Garland; Heidi Schutz; Mark A Chappell; Brooke K Keeney; Thomas H Meek; Lynn E Copes; Wendy Acosta; Clemens Drenowatz; Robert C Maciel; Gertjan van Dijk; Catherine M Kotz; Joey C Eisenmann Journal: J Exp Biol Date: 2011-01-15 Impact factor: 3.312
Authors: A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone Journal: Endocrinology Date: 2000-09 Impact factor: 4.736
Authors: Stacy L Schmidt; Kristin A Harmon; Teresa A Sharp; Elizabeth H Kealey; Daniel H Bessesen Journal: Obesity (Silver Spring) Date: 2012-04-23 Impact factor: 5.002
Authors: T Adage; A J Scheurink; S F de Boer; K de Vries; J P Konsman; F Kuipers; R A Adan; D G Baskin; M W Schwartz; G van Dijk Journal: J Neurosci Date: 2001-05-15 Impact factor: 6.167
Authors: Kristian Holtkamp; Beate Herpertz-Dahlmann; Claudia Mika; Martina Heer; Nicole Heussen; Manfred Fichter; Stephan Herpertz; Werner Senf; Werner F Blum; Ulrich Schweiger; Andreas Warnke; Anne Ballauff; Helmut Remschmidt; Johannes Hebebrand Journal: J Clin Endocrinol Metab Date: 2003-11 Impact factor: 5.958
Authors: Ana C Ribeiro; Giovanni Ceccarini; Christophe Dupré; Jeffrey M Friedman; Donald W Pfaff; Allyn L Mark Journal: PLoS One Date: 2011-08-10 Impact factor: 3.240
Authors: E Poggiogalle; L M Donini; C Chiesa; L Pacifico; A Lenzi; S Perna; M Faliva; M Naso; M Rondanelli Journal: J Endocrinol Invest Date: 2017-10-03 Impact factor: 4.256
Authors: Min Chen; Eric A Wilson; Zhenzhong Cui; Hui Sun; Yogendra B Shrestha; Brandon Podyma; Christina H Le; Benedetta Naglieri; Karel Pacak; Oksana Gavrilova; Lee S Weinstein Journal: Mol Metab Date: 2019-04-12 Impact factor: 7.422
Authors: Sharon E Mitchell; Camille Delville; Penelope Konstantopedos; Davina Derous; Cara L Green; Yingchun Wang; Jing-Dong J Han; Daniel E L Promislow; Alex Douglas; Luonan Chen; David Lusseau; John R Speakman Journal: Oncotarget Date: 2016-04-12
Authors: Kavaljit H Chhabra; Jessica M Adams; Graham L Jones; Miho Yamashita; Martin Schlapschy; Arne Skerra; Marcelo Rubinstein; Malcolm J Low Journal: Mol Metab Date: 2016-08-05 Impact factor: 7.422